Generate a tailored SOP for Dr. Andrew Ellisdon. Improve your application with a focused, well-structured draft.
Andrew Ellisdon is a Mid-Career Fellow and the Head of the Structural Biology Signalling Cancer Laboratory at the Monash Biomedicine Discovery Institute (BDI). His research team focuses on capturing an atomic resolution view of signaling actions by observing protein complexes formed by critical tumor-suppressor proteins and oncogenes. Using advanced techniques such as single-particle cryo-electron microscopy and classical biochemistry, he aims to enable novel insights into the molecular mechanisms underlying cancer. Ellisdon's work substantially contributes to the UN Sustainable Development Goals, specifically in research areas related to cancer treatment and drug development. His recent projects include research on therapeutically actionable signaling axes in poor prognosis cancers and exploring new therapeutics for neurofibromatosis-linked cancers. He actively collaborates with scientists across various countries and engages in projects aimed at defining clinical variances to discover new therapeutic targets.
Monash University • Melbourne, Australia
Leading the Structural Biology Signalling Cancer Laboratory.
Requirements are standardized across the Faculty of Information Technology for most Master's programs including Computer Science and Data Science.